CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 114 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $33,000 | +725.0% | 17,925 | +763.0% | 0.00% | – |
| Q1 2021 | $4,000 | -76.5% | 2,077 | -82.4% | 0.00% | – |
| Q4 2020 | $17,000 | +325.0% | 11,811 | +238.8% | 0.00% | – |
| Q3 2020 | $4,000 | -90.9% | 3,486 | -38.3% | 0.00% | – |
| Q2 2020 | $44,000 | -17.0% | 5,646 | -48.5% | 0.00% | – |
| Q1 2020 | $53,000 | -51.8% | 10,965 | -45.4% | 0.00% | – |
| Q4 2019 | $110,000 | -86.8% | 20,066 | -88.3% | 0.00% | – |
| Q3 2019 | $833,000 | -25.7% | 171,205 | +5.8% | 0.00% | -100.0% |
| Q2 2019 | $1,121,000 | +706.5% | 161,744 | +706.1% | 0.00% | – |
| Q1 2019 | $139,000 | +3375.0% | 20,064 | +2807.8% | 0.00% | – |
| Q4 2018 | $4,000 | -97.9% | 690 | -97.3% | 0.00% | – |
| Q3 2018 | $192,000 | +9500.0% | 25,344 | +7059.3% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 354 | -64.6% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |